Ureaplasma urealyticum osteomyelitis of the greater trochanter in a patient with multiple sclerosis using ocrelizumab - a case report

被引：0
|
作者：
Ruythooren, Fred [1 ,2 ]
Ghijselings, Stijn [1 ,2 ]
Depypere, Melissa [3 ]
Metsemakers, Willem-Jan [5 ,6 ]
Henckaerts, Liesbet [4 ,7 ]
Noppe, Nathalie [8 ]
Vles, Georges [1 ,2 ]
机构：
[1] Univ Hosp Leuven Gasthuisberg, Dept Orthopaed Surg, Leuven, Belgium
[2] Univ Hosp Leuven Gasthuisberg, Inst Orthopaed Res & Training IORT, Leuven, Belgium
[3] Univ Hosp Leuven Gasthuisberg, Dept Lab Med, Leuven, Belgium
[4] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Lab Clin Infect & Inflammatory Disorders, Leuven, Belgium
[5] Univ Hosp Leuven Gasthuisberg, Dept Trauma Surg, Leuven, Belgium
[6] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium
[7] Univ Hosp Leuven Gasthuisberg, Dept Gen Internal Med, Leuven, Belgium
[8] Univ Hosp Leuven Gasthuisberg, Dept Radiol, Leuven, Belgium
来源：
JOURNAL OF BONE AND JOINT INFECTION | 2024年 / 9卷 / 03期
关键词：
MYCOPLASMAS; ARTHRITIS;
D O I：
10.5194/jbji-9-167-2024
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Ocrelizumab - a monoclonal anti-CD20 antibody used in treatment of multiple sclerosis (MS) - marks significant progress in treating autoimmune diseases but raises susceptibility to opportunistic infections due to hypogammaglobulinemia. A young MS patient developed osteomyelitis from persistent Ureaplasma urealyticum urethritis, which was diagnosed with specialized polymerase chain reaction and resolved with targeted antibiotics. A multidisciplinary approach is crucial for managing such infections.
引用
收藏
页码：167 / 171
页数：5
相关论文
共 50 条
  • [21] RituximabHypogammaglobulinaemia, Ureaplasma urealyticum infection and brain abscess: case report
    Reactions Weekly, 2015, 1543 (1) : 193 - 193
  • [22] Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature review
    Jovicevic, Vanja
    Bila, Jelena
    Mesaros, Sarlota
    Pekmezovic, Tatjana
    Drulovic, Jelena
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (5-6) : 354 - 356
  • [23] ImmunosuppressantsHaemorrhagic cystitis secondary to Ureaplasma urealyticum infection: case report
    Reactions Weekly, 2018, 1721 (1) : 150 - 150
  • [24] Improvement in Thyroid Eye Disease with Ocrelizumab in a Patient With Co-existing Multiple Sclerosis: A Case Report
    Serrano, E.
    Safadi, A.
    Tornatore, C.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 65 - 65
  • [25] OcrelizumabBronchitis and Ureaplasma urealyticum septic hip arthritis: case report
    Reactions Weekly, 2025, 2055 (1) : 282 - 282
  • [26] Case Report: Rapid Desensitization to Ocrelizumab for Multiple Sclerosis Is Effective and Safe
    Aun, Marcelo Vivolo
    Freua, Fernando
    Marussi, Victor Hugo Rocha
    Giavina-Bianchi, Pedro
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case report
    Manzano, Giovanna S.
    Rice, Dylan R.
    Zurawski, Jonathan
    Jalkh, Youmna
    Bakshi, Rohit
    Mateen, Farrah J.
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 379
  • [28] Recurrent Skin and Soft Tissue Infections Caused by Ureaplasma urealyticum in an Immunocompromised Adult Patient: A Case Report
    Zhang, Min
    Huang, Hui
    Yang, Haichao
    Yang, Ge
    Wang, Wenwen
    He, Juying
    Wang, Guiyu
    Yang, Xichuan
    Zhai, Zhifang
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 6863 - 6868
  • [29] Severe Neonatal Asphyxia Associated with Ureaplasma urealyticum Infection: A Case Report
    Wang, Dandan
    Fan, Weiwei
    Yan, Tingting
    Yuan, Tianming
    Zhou, Xuchen
    AMERICAN JOURNAL OF CASE REPORTS, 2025, 26
  • [30] Viral pericarditis following ocrelizumab in a multiple sclerosis patient
    Miele, Giuseppina
    Abbadessa, Gianmarco
    Maida, Elisabetta
    Bonavita, Simona
    NEUROLOGICAL SCIENCES, 2023, 44 (08) : 2947 - 2949
12345